Screening and HPLC-Based Activity Profiling for New Antiprotozoal Leads from European Plants by Zimmermann, Stefanie et al.
Sci  Pharm   www.scipharm.at 
Research article  Open Access 
Screening and HPLC-Based Activity Profiling for 
New Antiprotozoal Leads from European Plants 
Stefanie ZIMMERMANN 
1,2, Semira THOMI 
1, Marcel KAISER 
2,  
Matthias HAMBURGER 
1, Michael ADAMS * 
1 
1 Departement of Pharmaceutical Sciences, Pharmaceutical Biology, University of Basel, Klingelbergstrasse 
50, 4056, Basel, Switzerland. 
2 Parasite Chemotherapy, Department of Medical Parasitology and Infection Biology, Swiss Tropical and 
Public Health Institute, Socinstrasse 57, 4002 Basel, Switzerland. 
* Corresponding author. E-mail: michael.adams@unibas.ch (M. Adams) 
Sci Pharm. 2012; 80: 205–213        doi:10.3797/scipharm.1111-13 
Published:   December 23
rd 2011      Received:   November 14
th 2011 
Accepted:   December 23
rd 2011 
This article is available from: http://dx.doi.org/10.3797/scipharm.1111-13 
© Zimmermann et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction 
in any medium, provided the original work is properly cited. 
Abstract 
Based on a survey of remedies used in Renaissance Europe to treat malaria, 
we prepared and screened a library of 254 extracts from 61 plants for 
antiplasmodial activity in vitro. HPLC-based activity profiling was performed for 
targeted identification of active constituents  in extracts. One of the most 
remarkable results was the identification of onopordopicrin, a germacranolide 
sesquiterpene lactone isolated from Arctium nemorosum as a potent inhibitor of 
P. falciparum  with an IC50  of 6.9 µM. It was tested similarly against 
Trypanosoma brucei rhodesiense, the parasite which causes African sleeping 
sickness. With an IC50 of 0.37 µM, onopordopicrin was one of the most potent 
natural products reported so far. Cytotoxicity was determined against rat 
myoblast L6 cells (IC50: 3.06). 
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Introduction 
Malaria is still the most deadly parasitic disease in the world, leading to one million deaths 
every year, mostly in Sub-Saharan Africa. In 1976 Trager and Jensen [1] developed a 
method for propagation of Plasmodium falciparum in human erythrocytes. This parasite 206  S. Zimmermann et al.:   
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species is the cause of malaria tropica, the most severe form of malaria in humans [2]. 
This  assay  opened up the possibility of  screening  large numbers of samples for 
antiplasmodial activity. One particular source of samples which deserves special attention 
is plants that local populations use to treat malaria in regions where it is endemic. This is a 
reasonable approach to lead discovery considering that nowadays P. falciparum malaria is 
treated with artemisinin-based combination therapies (ACT) such as artemether/ 
lumefantrine, artesunate/amodiaquine, artesunate/mefloquine and artesunate/sulfadoxine-
pyrimethamine [3]. Artemisinin is a natural compound isolated from the medicinal herb 
Artemisia annua L. (Asteraceae) which was used in China to treat fever including malaria. 
Combination of artemisinin derivatives with other antimalarial drugs is necessary, firstly to 
increase efficacy and secondly to prevent resistances [3]. 
More than 1200 plant species from 160 families have been described as  traditional 
antimalarial remedies, and hundreds of extracts and purified compounds from such plants 
have shown antiplasmodial activities tested in the last decades [4]. Bero et al [5] recently 
reviewed more than 300 antiplasmodial (IC50s < 11 µM) plant compounds isolated from 
traditionally used plants, all of which had been published in the three years from 2005 
through 2008. Among them were 31 compounds with IC50 below 2 μM, which were termed 
“promising” compounds [5]. They argued that “ethnopharmacological approaches appear 
to be a promising way to find plant metabolites that could be used as templates for 
designing new derivatives with improved properties".  Willcox recently reviewed  clinical 
studies including 18 case studies and 39 cohort studies on traditional herbal malaria 
treatments [6].  
Malaria is nowadays mostly seen as a tropical disease, and it is common in tropical 
countries where most indigenous knowledge and plants are collected. Yet, all through 
history and until the 20
th  century malaria caused by P. vivax  and  P. malariae  was 
widespread in Europe [7]. We recently did a search in eight herbals in German language 
from the 16
th and 17
th centuries and identified 314 plants that had been used to treat what 
was then known as tertian (P. vivax) and quartan (P. malariae) fever. However, one finding 
from this study was that only five percent  of these plants  had ever been studied for 
antiplasmodial effects and only one had been assayed in vivo [8].  
Considering the apparent lack of exploitation of this knowledge, we set out for a screening 
involving plants identified in our survey. We purchased or collected 61 European medicinal 
plants from various sources (see Table S1 in the Supporting Information), 34 of which had 
been described as antimalarials in the herbals [8]. The other 27 were taken as a control 
group, as they too were commercial medicinal plants or plants from genera which had 
medicinal uses. The plants were dried, separated in different parts (roots, aerial parts, 
flowers, etc) and extracted successively with n-hexane, ethyl acetate, and methanol to 
give three extracts of increasing polarity for each sample. This focused extract library was 
then tested for in vitro  inhibition of  P. falciparum. Follow-up of active extracts was by 
HPLC-based activity profiling to identify the active constituents [9]. We recently adapted 
and validated this approach for the miniaturized and efficient identification of antiprotozoal 
compounds in complex plant and fungal extracts [10] and have successfully applied it to 
discovery of new antiprotozoal natural products in other library-based discovery projects 
[11–17].    Screening and HPLC-Based Activity Profiling for New Antiprotozoal Leads from European Plants  207 
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Results and Discussion 
Two hundred and fifty-four extracts were prepared from 61 plants and tested for 
antiplasmodial activity at two test concentrations (0.8 and 4.8 µg/ml) according to an 
established procedure. The identity of the plants, their botanical authority, their origin, the 
plant part used, the extraction solvent and the % inhibition with the standard deviation as 
the mean of the three repetitions are all shown in Table S1.  
Nine of the 10 most active extracts in this screen (at 4.8 µg/ml) were from plants with a 
documented antimalarial use in Renaissance herbals [8] (Table S1). These included the 
petroleum  ether extract of the aerial parts of Peucedanum ostruthium  (L.) Koch (71% 
inhibition), the ethyl acetate extract of the roots of Asparagus officinalis L. (75%), the ethyl 
acetate extract of the aerial parts of Artemisia abrotanum L. (69%), the petroleum ether 
extract of the leaves of Artemisia absinthium L. (68%), the ethyl acetate extract of the roots 
of  Inula conyzae  (Griess.)  Meikle  (66%), the ethyl acetate extract of the flowers of 
Humulus lupulus L. (96%), the ethyl acetate extract of the roots of Anacyclus pyrethrum 
(L.) Link (65%), the ethyl acetate extract of the aerial parts of Hypericum perforatum L. 
(98%), and the petroleum ether extract of the aerial parts of Hyssopus officinalis L. (66%). 
Finally, the ethyl acetate extract of the leaves of Arctium nemorosum Lej., which had no 
record of antimalarial use, was particularly effective (99%). 
Some of the active plants, including Peucedanum ostruthium,  Asparagus officinalis, 
Humulus lupulus, Artemisia absinthium and Hypericum perforatum had previously been 
studied for antiplasmodial effects by other groups (see [8]) and were therefore not followed 
up in this study. We decided to proceed with HPLC-based activity profiling with the active 
extracts from Arctium nemorosum  and  Hyssopus officinalis  to determine their active 
constituents. The lack of previous phytochemical studies of A. nemorosum made this plant 
species in particular interesting to us.  
Hyssopus officinalis L. 
The HPLC-based activity profile of the H. officinalis extract showed that the activity was 
concentrated in one major time window at minute 26, which also contained the most 
dominant peak in the chromatogram (Fig. 1).  
HR-HPLC-MS (method shown in the Supporting Information) analysis of the peak with the 
retention time 25.3 minutes showed m/z  293.4263 [M-H]
−, which was indicative of a 
molecular formula of C18H30O3 (calc. for 294.4290). 
The compound corresponding to this peak was then isolated by the following procedure: 
Two kilograms of dried and finely ground aerial parts of Hyssopus officinalis (Dixa AG 
Herbs and Spices, St. Gallen, Switzerland) were extracted three times with eight L of 
n-heptane, which yielded 19 g of a dark viscous extract. MPLC was done to separate 5 g 
extract into 129 fractions (Method 1). Fractions were analysed by HPLC-ESI-MS and TLC 
(see Supporting Information) after every separation step to identify fractions containing 
targeted compound 1. Fractions F80-85 were pooled and preparative HPLC (see Supporting 
information) was applied to isolate 0.5 mg of 1. By comprehensive use of HR-MS, 1D and 
2D NMR, and comparison with literature [17], 1 was identified as 13-oxo-9Z,11E-octadeca-
dienoic acid (1, Fig. 2). This compound was previously reported from H. officinalis [18].  208  S. Zimmermann et al.:   
Sci Pharm. 2012; 80: 205–213 
 
Fig. 1.   Activitiy profiling of Hyssopus officinalis. The antiplasmodial activity of the 32 
one-minute microfractions is plotted against the mass trace of the petrol ether 
extract (ESI-ESI positive scan m/z 150–1500).  
This prompted us to test a series of saturated and unsaturated fatty acids for their 
antiplasmodial effects alongside 1. These compounds were 10-cis-heptadecenoic acid, 
11-cis-eicosenoic acid, 13-cis-docosenoic acid, methyl linoleate, linoleic acid, caproic acid, 
docosanoic acid, arachidic acid, 9,12,15-all-cis-octadecaterienic acid, and caprylic acid. 
Neither 1 nor any of these fatty acids had more than 50% inhibition at a test concentration 
of 10 µg/mL.  
1
O
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Fig. 2.  13-Oxo-9Z,11E-octadecadienoic acid 
Arctium nemorosum Leij.  
The HPLC-based activity profile of the A. nemorosum extract showed that the major peak 
of activity was concentrated in one major time window at minute 12. This time window also 
contained the most dominant peak in the chromatogram (Fig. 4). HR-HPLC-MS analysis 
(method in the Supporting Information) of the peak with retention time 12.6 min showed 
m/z 719.3088 [2M+Na]
+, which was indicative of a molecular formula of C29H24O6 (calc. for 
348.1580). 
   Screening and HPLC-Based Activity Profiling for New Antiprotozoal Leads from European Plants  209 
Sci Pharm. 2012; 80: 205–213 
 
Fig. 3.  Arctium nemorosum Leij., May 2011 (by S. Zimmermann), The river Rhine in 
the background. 
The aerial parts of A. nemorosum (28.6 g) were milled and extracted exhaustively with 
EtOAc to afford 1.16 g of dried extract. The active peak at RT 12.5 seen in the HPLC-
based activity profiling (Fig. 4) was isolated by semi-preparative HPLC (Method 1) yielding 
5.71 mg. The structure was established by comprehensive analysis of HR-MS and 2D 
NMR data as the germacranolide sesquiterpene lactone onopordopicrin (2, Fig. 5). NMR 
and MS data was in accordance with literature [19]. Onopordopicrin has been previously 
reported as constituent in leaves of Onopordum acanthium  L. and Arctium lappa  L. 
[19, 20]. 
 
Fig. 4.   Activity profiling of Arctium nemorosum. The antiplasmodial activity of the 32 
one-minute microfractions is plotted against the mass trace of the ethyl acetate 
extract (ESI-ESI positive scan m/z 150–1500).  
Onopodopicrin (2) was an effective inhibitor of P. falciparum parasite growth, with an IC50 
of 6.89 ± 0.56 µM. The compound shares some structural features, such as the lactone 
ring with an exocyclic methylene group, and a 2-(hydroxymethyl) acrylate side chain, with 
cynaropicrin, which we recently identified as an in vivo  active compound in the acute 
T. brucei rhodesiense sleeping sickness mouse model [16]. Therefore, we tested 2 against 
T. brucei rhodesiense in vitro as well. Onopordopicrin (2) showed potent activity with an 210  S. Zimmermann et al.:   
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IC50 value of 0.37 ± 0.01 µM. Against rat myoblast cells (L6 cells) it was cytotoxic with an 
IC50 of 3.06 ± 1.1 µM, and thus a selectivity index (SI) of 8.3.  
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Fig. 5.  Onopodopicrin 
In summary, 254 extracts from 61 medicinal plants  (Table S1) were prepared and 
screened for antiplasmodial effects. Thirty-four of the plants had been described as 
antimalarials  in German Renaissance herbals  [8] and 27 were regarded as a control 
group. Amongst the most potent 10 extracts, nine were from those plants which had had 
an antimalarial use. Arctium nemorosum, a plant which was very active, was not reported 
in the herbals [8]. However, the closely related species Arctium lappa had been used as a 
traditional malaria remedy (Table S1).  The extracts  of  A. lappa  were included in this 
screening, too, and showed slightly lower activity against P. falciparum  than  A. 
nemorosum  (Table S1). HPLC-based activity profiling was done with two of the active 
extracts, namely the petroleum ether extract of Hyssopus officinalis and the ethyl acetate 
extract of Arctium nemorosum. In both cases the active compounds were rapidly identified 
and isolated. In the case of H.  officinalis  the  isolated compound was 13-oxo-9Z,11E-
octadecadienoic acid, an unusual keto fatty acid. Tested as a pure compound its IC50 was 
higher than the highest test concentration of 10 µg/ml. A possible explanation for this may 
be that due to its high concentration in the extract, the compound nevertheless showed up 
in the activity profile (Fig. 1). Thus, the presence of “false positives”, that is, major and with 
weak activity must be considered when applying these approaches. Also, it may be that 
another compound we could not detect was present in this time window and was 
responsible for the observed activity.  
In the case of Arctium nemorosum  onopordopicrin (2) was identified as being chiefly 
responsible for the observed activity. Its in vitro antiplasmodial (P. falciparum IC50= 6.89 ± 
0.56) and antitrypanosomal (T. b. rhodesiense IC50= 0.37 ± 0.01) effects were similar to 
those of cynaropicrin (P. falciparum IC50= 3.00 ± 0.28; T. b. rhodesiense IC50= 0.28 ± 001, 
L6-cells IC50= 2.19 ± 0.27),  which has previously  been  shown to possess in vivo 
antitrypanosomal activity [17]. HPLC-based activity profiling is thus a fast and efficient 
method for identifying active compounds in complex extracts [9, 10]. The selection of 
traditionally used plants for a focused screening as a rational approach to lead discovery is 
supported here. 
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Experimental 
Analytical grade solvents for extraction and HPLC grade solvents for chromatography 
were purchased from Scharlau (Barcelona, Spain). HPLC grade water was obtained by an 
EASY-pure II (Barnstead; Dubuque IA, USA) water purification system. 
Plant material 
Plant material was purchased from commercial sources or collected by the author (M. 
Adams), and voucher specimens were deposited at the Department of Pharmaceutical 
Sciences, University of Basel. Origins and voucher numbers are shown in the Supporting 
Information. 
Extraction of plant material for screening 
Plants were dried and separated into different parts (roots, aerial parts, flowers) and finely 
ground  using a ZM1 ultra centrifugal mill (Retsch; Haan, Germany).  1 g of powdered 
material was then successively extracted first with petroleum ether, then ethyl acetate and 
finally methanol using an accelerated solvent extraction system ASE (ASE 200, Dionex, 
Switzerland; 3 cycles at 120 bar, and 70°C) to give a set of three extracts of increasing 
polarity for every sample. The extracts were formatted into a library of solutions at 10 
mg/ml  DMSO in 2D-barcoded 96 well plates (Zinsser Analytics, France) and stored at   
−80° C, until used for screening and for HPLC-based activity profiling. 
Screening of extracts for antiplasmodial activity 
The antiplasmodial screening was performed as previously described [8]. Tests were 
repeated three times in duplicate, at test concentrations of 0.8 and 4.8 µg/ml. 
HPLC-based activity profiling  
Selected extracts were separated by analytical HPLC for activity profiling as previously 
reported [10], with the following modifications: extracts were separated by HPLC into 96-
deep well plates (ScreenMates 96 well, Matrix Technology, Hudson, USA) and dried within 
2 h in a parallel evaporator (EVX-96 Apricot Evaporex, Monrovia, USA), with an N2-stream 
(60 °C upper part/ 40°C lower part). The dried microfractions were dissolved in 50 µl 
methanol and transferred into 96 well conical plates (V-well plates, Thermo Scientific, 
USA). After rinsing with 50 µl MeOH, the plate was again dried using the same condition 
as described above. The dried microfractions were dissolved in 5 µL of DMSO and then 
diluted with 95 µL of PBS buffer (137 mM NaCl, 10 mM phosphate, 2.7 mM KCl, pH 7.4). 
This gave the stock solutions which could be used for the assays [10]. On-line collection of 
mass spectral data was done by LC ion trap ESI-MS and HR-TOF-MS [10]. Details are 
given in the Supporting Information. 
Bioassays 
Screening of extracts, HPLC-based activity profiling and pure compounds were tested as 
previously described [10, 17]. Tests were done in three independent assays in duplicate. 
For details please refer to the Supporting Information.  
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